IVD Medical Holding (HKSE:01931) Accounts Receivable : HK$582 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is IVD Medical Holding Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. IVD Medical Holding's accounts receivables for the quarter that ended in Dec. 2023 was HK$582 Mil.

Accounts receivable can be measured by Days Sales Outstanding. IVD Medical Holding's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 56.76.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. IVD Medical Holding's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was HK$0.60.

IVD Medical Holding Accounts Receivable Historical Data

The historical data trend for IVD Medical Holding's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVD Medical Holding Accounts Receivable Chart

IVD Medical Holding Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Receivable

Get a 7-Day Free Trial

434.45

504.23

667.48

632.95

582.06

IVD Medical Holding Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Receivable	Get a 7-Day Free Trial									667.48	525.70	632.95	537.09	582.06

IVD Medical Holding Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

IVD Medical Holding Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

IVD Medical Holding's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	582.063	/	1871.536	*	91
=	56.76

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), IVD Medical Holding's accounts receivable are only considered to be worth 75% of book value:

IVD Medical Holding's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1339.645	+	0.75 * 582.063	+	0.5 * 1213.607	-	1530.375
-	0	-	44.795)	/	1354.59
=	0.60

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

IVD Medical Holding Accounts Receivable Related Terms

Thank you for viewing the detailed overview of IVD Medical Holding's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

IVD Medical Holding (HKSE:01931) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » IVD Medical Holding Ltd (HKSE:01931) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 299, Bisheng Road, Room 602, Building 6, Zhangjiang Hi-Tech Park, Pudong New Area District, Shanghai, CHN

Website

http://www.ivdholding.com

IVD Medical Holding Ltd is principally engaged in the sale and manufacture of medical equipment and consumables and the provision of consultancy and maintenance services related to medical equipment. It has three segments. The distribution business, which is the key revenue driver, involves the trading of IVD analysers, reagents, and other consumables to customers such as distributors, hospitals and healthcare institutions, and logistics providers. The After-sales Services provided by Vastec include maintenance and repair services, installation services and end-customer training. Its Self-branded Products Business, distributes its self-developed IVD products under its own brand which includes IVD analysers and reagents under the IVD testing category of Point-of-care testing.

Executives

Leung King Sun
Wu Meizhen	2201 Interest of corporation controlled by you
China International Trust Limited	2201 Interest of corporation controlled by you
Wu Yanfeng	2201 Interest of corporation controlled by you
Wu Mingcong	2201 Interest of corporation controlled by you
Wu Junfeng	2201 Interest of corporation controlled by you
Shen Li	2201 Interest of corporation controlled by you
Nd Medical Technology Limited	2201 Interest of corporation controlled by you
Ma Zhouwei	2201 Interest of corporation controlled by you
Hong Kong Medicine Group Limited	2201 Interest of corporation controlled by you
Hknd Gene Biotechnology Limited	2201 Interest of corporation controlled by you
Fast Benefit Pharmaceutical Limited	2201 Interest of corporation controlled by you
China Smart Pharmaceutical Technology Limited	2201 Interest of corporation controlled by you
3w.com Holding Limited	2201 Interest of corporation controlled by you
Morgan Stanley	2201 Interest of corporation controlled by you

IVD Medical Holding (HKSE:01931) Headlines

No Headlines